Whether intravitreal injection of hyaluronic acid (HA; 0.3 mL of 14 mg/mL Healon GV) in presbyopic monkeys could restore accommodative responses (lens thickening, ciliary muscle movement, choroidal movement, dioptric amplitude) compared to baseline, measured over up to 16 months post-injection using refractometry, UBM, and OCT.
Two weeks after HA injection, accommodative amplitude increased by 1.19 ± 0.79 diopters, lens thickening by 0.24 ± 0.05 mm, forward ciliary muscle movement by 0.42 ± 0.09 mm, centrifugal choroidal movement by 0.47 ± 0.19 mm, and anterior lens surface curvature improved by 2.43 ± 0.49 mm radius of curvature; these effects were maintained up to 16 months post-injection, with no change in the untreated contralateral eye.
Study conducted in monkeys (n not fully reported for all endpoints; n=2 for EW stimulation subgroup), limiting direct translation to humans; pilocarpine was used pharmacologically to induce accommodation rather than natural neural stimulation for most endpoints; the study lacks a sham-injection control group.
Restoring vitreous HA levels via intravitreal injection may durably improve accommodative mechanics in presbyopic eyes, suggesting a potential therapeutic avenue for presbyopia, though clinical translation requires human trials. Clinicians interested in presbyopia treatment or accommodating IOL design may watch this line of research closely.